Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous. To capitalize on that opportunity, however, health systems ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Proteins are central to cellular function, yet traditional proteomics methods—including mass spectrometry-based and affinity-based approaches—face challenges in resolving proteoforms, the distinct ...

The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market is expected to reach $8.77b by 2030 at a compound annual growth rate (CAGR) ...

Single-cell sequencing is useful for a number of applications. For example, it can reveal cellular heterogeneity inside complex tissues, such as tumors. It can also provide information about how ...

The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...

A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Routine newborn screening (NBS) has transformed early disease ...